RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer-Reference-Cited by-同舟云学术

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Published:2015-03-11 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Niederst Matthew J.,Sequist Lecia V.,Poirier John T.,Mermel Craig H.,Lockerman Elizabeth L.,Garcia Angel R.,Katayama Ryohei,Costa Carlotta,Ross Kenneth N.,Moran Teresa,Howe Emily,Fulton Linnea E.,Mulvey Hillary E.,Bernardo Lindsay A.,Mohamoud Farhiya,Miyoshi Norikatsu,VanderLaan Paul A.,Costa Daniel B.,Jänne Pasi A.,Borger Darrell R.,Ramaswamy Sridhar,Shioda Toshi,Iafrate Anthony J.,Getz Gad,Rudin Charles M.,Mino-Kenudson Mari,Engelman Jeffrey A.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms7377.pdf

Reference37 articles.

1. Mok, T. S. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. New Engl. J. Med. 361, 947–957 (2009) .

2. Mitsudomi, T. et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol. 11, 121–128 (2010) .

3. Maemondo, M. et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. New Engl. J. Med. 362, 2380–2388 (2010) .

4. Rosell, R. et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 13, 239–246 (2012) .

5. Sequist, L. V. et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J. Clin. Oncol. 31, 3327–3334 (2013) .

Cited by 545 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma;JTO Clinical and Research Reports;2024-09

2. An identity crisis for lung cancer cells;Science Translational Medicine;2024-08-14

3. Mechanisms governing lineage plasticity and metabolic reprogramming in cancer;Trends in Cancer;2024-08

4. CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation;Signal Transduction and Targeted Therapy;2024-07-26

5. Transdifferentiation of metastatic melanoma into cerebellar angiosarcoma;Journal of Neuropathology & Experimental Neurology;2024-07-04